Clinical Site Manager, Western Region
AlconSalary not specified
- Full Time
- Junior (1 to 2 years)
$60,000 – $80,000Compensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Clinical Research, BiotechIndustries
Requirements
Candidates should possess a Bachelor’s degree in a life science field, a minimum of 8 years of clinical research experience at a Pharmaceutical, Biotech, or CRO company with global proficiency, at least 2 years of experience as a clinical trial manager in the eyecare industry, and a minimum of 2 years of vendor management experience including CROs and labs. Additionally, one year of site monitoring experience, including qualification, initiation, and monitoring, is required.
Responsibilities
The Manager II, Clinical Trials will oversee and manage key study activities such as study start-up, development of study plans, vendor management, drug inventory, lab supplies, and sample management, while also reviewing protocols, CRFs, and other study documents. They will participate in user acceptance testing, develop training materials and site study materials, assist in site qualification, ensure study staff are properly trained, arrange and oversee site visits, provide Sponsor oversight of monitoring activities, organize presentations, manage drug supply inventory, review study budgets, assist in creating project tools, review Clinical Study Reports, and serve as a resource for others within the company. Furthermore, the role involves developing study timelines, managing study finances and forecasting, and working cross-functionally to report on study status and strategy.
Skills
Protocol Development
CRF Development
Vendor Management
CRO Management
Site Monitoring
Study Start-up
Budget Management
Clinical Study Reporting
Training Material Development
Project Management
Tarsus Pharamceuticals
Develops treatments for eye care diseases
About Tarsus Pharamceuticals
Tarsus Pharmaceuticals develops treatments for diseases that lack effective solutions, focusing mainly on eye care and infectious diseases. Their key product, XDEMVY, is an FDA-approved eye drop solution used to treat Demodex Blepharitis, a condition affecting the eyelids. The company is also working on other potential treatments for conditions such as Lyme Disease Prevention, Meibomian Gland Disease, and Rosacea. Tarsus differentiates itself from competitors by concentrating on specific medical needs and maintaining a strong pipeline of future products. Their goal is to provide effective treatments for patients suffering from these conditions while ensuring compliance with regulations and ethical standards.
Irvine, CaliforniaHeadquarters
2017Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees